COSCIENS Biopharma Inc. (TSX:CSCI)
8.25
-0.35 (-4.07%)
Nov 19, 2026, 11:10 AM EST
COSCIENS Biopharma Market Cap
COSCIENS Biopharma has a market cap or net worth of CAD 8.23 million as of November 19, 2026. It is the 44,016th most valuable company in the world and the 1,627th biggest in Canada. Its market cap has decreased by 12.68% in one year.
Market Cap
8.23M
Enterprise Value
15.16M
Revenue
13.85M
Global Rank
Country Rank
#1,627 Canada
PE Ratio
1.23
ChartMarket Cap Chart
Since April 22, 1996, COSCIENS Biopharma's market cap has decreased from 44.46B to 8.23M, a decrease of -99.98%. That is a compound annual growth rate of -24.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 8.23M | -9.00% |
| Dec 31, 2025 | 9.04M | 30.63% |
| Dec 31, 2024 | 6.92M | -44.54% |
| Dec 29, 2023 | 12.48M | -40.23% |
| Dec 30, 2022 | 20.88M | -62.20% |
| Dec 31, 2021 | 55.24M | 63.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Onco-Innovations | 14.54M |
| Rapid Dose Therapeutics | 13.78M |
| Alzai Health | 13.61M |
| Britannia Life Sciences | 11.52M |
| Marvel Biosciences | 9.59M |
| Hemostemix | 7.40M |
| Rakovina Therapeutics | 7.13M |
| Glow Lifetech | 6.74M |